key: cord-0078834-rs8lq3bv authors: Maurer, Maureen; Seto, Todd; Guest, Claire; Somal, Amendeep; Julian, Catherine title: Detection of SARS-CoV-2 by Canine Olfaction: A Pilot Study date: 2022-05-07 journal: Open Forum Infect Dis DOI: 10.1093/ofid/ofac226 sha: 6f7bef10f3d75244291770170b93beda9338b6df doc_id: 78834 cord_uid: rs8lq3bv BACKGROUND: As the number of COVID-19 cases continue to surge worldwide and new variants emerge, additional accurate, rapid, and non-invasive screening methods to detect SARS-CoV-2 are needed. The number of COVID-19 cases reported globally is over 455 million and deaths have surpassed 6 million. Current diagnostic methods are expensive, invasive, and produce delayed results. While COVID-19 vaccinations are proven to help slow the spread of infection and prevent serious illness, they are not equitably available worldwide. Almost 40% of the world’s population remains unvaccinated. Evidence suggests that SARS-CoV-2 virus-associated volatile organic compounds found in the breath, urine, and sweat of infected individuals can be detected by canine olfaction. Medical detection dogs may be a feasible, accurate and affordable SARS-CoV-2 screening method. METHODS: In this double-blinded, case-control, validation study, we obtained sweat samples from inpatients and outpatients tested for SARS-CoV-2 by a polymerase chain reaction test. Medical detection dogs were trained to distinguish SARS CoV-2 positive samples from SARS-CoV-2 negative samples, using reward-based reinforcement. RESULTS: Samples were obtained from 584 individuals (6 to 97 years of age; 24% positive SARS CoV-2 samples and 76% negative SARS CoV-2 samples). In the Testing Phase, all dogs performed with high accuracy in detecting SARS-CoV-2: overall diagnostic sensitivity was 98% and specificity was 92%. In a follow-up phase, one dog screened 153 patients for SARS-CoV-2 in a hospital setting with 96% diagnostic sensitivity and 100% specificity. CONCLUSIONS: Canine olfaction is an accurate and feasible method for diagnosis of SARS-CoV-2, including asymptomatic and pre-symptomatic infected individuals. The pandemic continues to surge worldwide as more virulent and contagious variants emerge. Early diagnosis and quarantine remain key strategies to reduce transmission of the virus. 14 However, the effectiveness of these strategies is dependent upon timely testing and screening 15 methods that identify individuals infected with the virus, especially before symptom onset [6] . 16 Thermal screening is utilized as a method for detecting COVID-19, but this screening method 17 alone is an ineffective marker of viral infection, as it has low sensitivity rates and can miss more various diseases including prostate and other cancers [12, 13] , and bacteria in blood samples, but 12 currently there is no device for use in clinical practice [14] . Dogs were shown to outperform 13 current technology in a recent prostate cancer detection study [15] . In another study, dogs 14 indicated a detection limit of less than 0.001 parts per billion (ppb) (1 × 10 -12 ) [16], while 15 "electronic noses" had a detection threshold of 100 to 400 (ppb) (1 × 10 -7 ) [17] . 16 Canine scent detection is gaining attention as an effective and reliable method for identifying 17 infections, viruses, and diseases [18, 19] . Dogs' olfactory acuity is over 100,000 times stronger 18 than humans, with the ability to detect odors in parts per trillion [16, 20] These findings suggest that trained medical detection dogs may present a novel method for 10 screening and detecting SARS-CoV-2 infected individuals, including those who are 11 asymptomatic or pre-symptomatic as well as those infected with different variants. However, 12 samples have primarily consisted of blood, bronchial secretions, etc., which are more challenging 13 to collect and less applicable in real-world SARS-CoV-2 screening scenarios. Sweat is a bodily 14 odor that can be immediately and non-invasively screened by medical detection dogs. Our primary objective for this study was to determine the ability of medical detection dogs to 16 distinguish SARS-CoV2 positive (case) sweat samples from SARS-CoV2 negative (control) 17 sweat samples using efficient methodology that can be implemented in real-world settings. This subjects with symptoms suggestive of COVID-19 and for asymptomatic subjects who may have 7 been exposed to COVID-19 or were required to test for work, travel, etc. At the time of sample 8 collections, subjects were asked if they had symptoms of COVID-19. We included subjects who 9 were symptomatic and asymptomatic, and those who were hospitalized and non-hospitalized. We 10 excluded those who had a prior positive COVID-19 RT-PCR test within the prior 90 days, and 11 those hospitalized with severe COVID-19 (e.g., requiring mechanical ventilation). There were no 12 other restrictions. We defined "cases" as those who were COVID-19 RT-PCR positive and 13 "controls" as those who were COVID-19 RT-PCR negative. 14 Patient Consent Statement 15 We received institutional review board (IRB) approval by The Queen's Medical Center 16 Institutional Review Committee. The study involved no more than minimal risk to subjects and 17 written consent was obtained for study participation. Maui, HI). The training room was 9.14 square meters, temperature controlled (21-26° C) and 22 cleaned at the end of each day using an unscented, non-toxic cleaner. The laboratory room (3.04 meters x 3.66 meters) was adjacent to the training room, with a one-way privacy window which 1 allowed researchers to observe double-blinded runs. Samples were stored in a refrigerator (1.8 -2 3.3° C). Samples were removed from the refrigerator prior to the run in which they were used 3 and discarded immediately after each session. Sample handlers wore standard personal protective 4 equipment. The hypoallergenic cotton pads containing the skin odor samples collected from study 6 participants were transferred to sterile 4-ounce specimen cups (Thomas Scientific) and then Table 1 ). The data 8 recorder entered the results of each testing run on paper forms, and at the end of each day, the 9 data was entered into an electronic spreadsheet for analysis. All testing runs were video-recorded 10 and audited daily. Table 2) . 6 Individually, the three dogs all had excellent sensitivity, varying slightly from 0.96 to 1.00. Specificity was also excellent and varied slightly more (0.87 to 0.99) ( Table 2) Economic impact of COVID-19 pandemic on 2 healthcare facilities and systems: international perspectives COVID-19 on the travel and tourism industry Impact of Covid-19 pandemic on education system Vaccination reduces need for emergency care in 10 breakthrough COVID-19 infections: a multicenter cohort study. The Lancet Regional Health 11 Recent Advancements in the diagnosis, prevention, 13 and prospective drug therapy of COVID-19 Contact tracing efficiency, transmission heterogeneity, and 16 accelerating COVID-19 epidemics Estimated 19 effectiveness of symptom and risk screening to prevent the spread of COVID-19 Molecular diagnostic technologies for COVID-19: Limitations and challenges A double blind, prospective study for prostate cancer diagnosis in urine 6 sample: accuracy of the electronic nose compared to highly trained dogs Naturalistic quantification of canine olfactory 9 sensitivity Evidence for 11 cancer biomarkers in exhaled breath Canine olfactory 13 detection and its relevance to medical detection Feasibility of 16 integrating canine olfaction with chemical and microbial profiling of urine to detect lethal 17 prostate cancer Canine olfactory thresholds to amyl acetate in a 20 biomedical detection scenario Can the 6 detection dog alert on COVID-19 positive persons by sniffing auxiliary sweat samples? A 7 proof of concept study Discrimination of SARS-CoV-2 infected patient samples 9 by detection dogs: a proof of concept study Scent dog identification of samples from COVID-19 12 patients -a pilot study Preliminary accuracy of COVID-19 odor detection by 15 canines and HS-SPME-GC-MS using exhaled breath samples Discrimination of SARS-CoV-2 infections from 18 other viral respiratory infections by scent detection dogs The detection dogs test is more sensitive than 21 real-time PCR in screening for SARS-CoV-2